Overview

Effect of Actonel on Periodontal Health of Postmenopausal Women

Status:
Unknown status
Trial end date:
2011-01-01
Target enrollment:
0
Participant gender:
Female
Summary
Hypothesis: Women who use Actonel (risedronate) for osteopenia will show beneficial periodontal effects.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
University Hospitals Cleveland Medical Center
Treatments:
Risedronate Sodium
Risedronic Acid
Criteria
Inclusion Criteria:

- Osteopenia

- Postmenopausal

Exclusion Criteria:

- Male

- Diabetes